(1)
The UK-headquartered bioelectronics company has set its sights on the US healthtech market following a series of new investors, new product developments and a 156% sales increase.
Leading bioelectronic innovator NuroKor BioElectronics has announced plans to ramp up its US expansion, following 12 months of rapid growth during which the company s half-year sales rose by 156%.
NuroKor, which pioneers the development of wearable technology that uses bioelectric nerve, muscle and microcurrent stimulation to help manage pain and optimise physical performance, has today announced a major new partnership with Medi-Launch Partners, as well as the onboarding of Florida-based U.S investors.
Medi-Launch Partners, the New York and Southern California-based enterprise, specialises in the launch and distribution of pioneering medical devices and will be working with NuroKor to optimise the commercial success of NuroKor s mibody and newly developed mediliev Rx devices across the US through